Urine Microalbumin

Urine

The Urine Microalbumin test panel is a critical diagnostic tool used primarily for early detection of kidney damage, particularly in patients with diabetes, hypertension, or other risk factors for chronic kidney disease. This panel typically includes the measurement of microalbumin, a small protein that should be minimally present in urine, and creatinine, a waste product from muscle metabolism. The key parameter often assessed is the Microalbumin/Creatinine Ratio (ACR), which provides a more accurate indication of kidney function by normalizing the amount of albumin to the creatinine level. This adjustment is essential as it accounts for variations in urine concentration, offering a reliable assessment of albumin excretion. Elevated levels of microalbumin in the urine, or an increased ACR, are early indicators of kidney dysfunction, signaling that the kidneys' filtering system is allowing albumin to leak into the urine. This test panel is an essential aspect of managing patients with conditions that affect kidney health, enabling early detection of kidney damage. Regular monitoring with the Urine Microalbumin test can lead to timely intervention, potentially slowing the progression of kidney disease and improving patient outcomes. Additionally, this test is useful for assessing cardiovascular risk, as microalbuminuria has been linked to an increased risk of heart disease and stroke in both diabetic and non-diabetic populations.

Urine Microalbumin

Biomarkers included in this panel:

Creatinine, Urine

Microalb, Ur

Microalbumin/Creatinine Ratio

All Categories